Form 8-K - Current report:
SEC Accession No. 0001437749-24-001386
Filing Date
2024-01-16
Accepted
2024-01-16 16:03:40
Documents
13
Period of Report
2024-01-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20240116_8k.htm   iXBRL 8-K 28512
  Complete submission text file 0001437749-24-001386.txt   175282

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA govx-20240116.xsd EX-101.SCH 3851
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20240116_def.xml EX-101.DEF 13383
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20240116_lab.xml EX-101.LAB 17550
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20240116_pre.xml EX-101.PRE 13360
7 EXTRACTED XBRL INSTANCE DOCUMENT govx20240116_8k_htm.xml XML 4269
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 24535154
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)